These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Allen JC; Donahue B; DaRosso R; Nirenberg A Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038 [TBL] [Abstract][Full Text] [Related]
3. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544 [TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: early results of a pilot study. Prados MD; Wara WM; Edwards MS; Cogen PH Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):431-8. PubMed ID: 8276658 [TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250 [TBL] [Abstract][Full Text] [Related]
6. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826 [TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Paulino AC; Melian E Cancer; 1999 Jul; 86(1):142-8. PubMed ID: 10391574 [TBL] [Abstract][Full Text] [Related]
8. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation. Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216 [TBL] [Abstract][Full Text] [Related]
9. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy? Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962 [TBL] [Abstract][Full Text] [Related]
11. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system. Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848 [TBL] [Abstract][Full Text] [Related]
12. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET. Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071 [TBL] [Abstract][Full Text] [Related]
14. Treatment results for 149 medulloblastoma patients from one institution. Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373 [TBL] [Abstract][Full Text] [Related]
15. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor. Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681 [TBL] [Abstract][Full Text] [Related]
16. Low-dose craniospinal radiation therapy for medulloblastoma. Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939 [TBL] [Abstract][Full Text] [Related]
17. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268 [TBL] [Abstract][Full Text] [Related]
18. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors. Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484 [TBL] [Abstract][Full Text] [Related]
19. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Chin D; Sklar C; Donahue B; Uli N; Geneiser N; Allen J; Nirenberg A; David R; Kohn B; Oberfield SE Cancer; 1997 Aug; 80(4):798-804. PubMed ID: 9264364 [TBL] [Abstract][Full Text] [Related]